This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 August 2020 and includes updates on the Ebola virus disease eleventh outbreak in the Democratic Republic of the Congo, Middle East respiratory syndrome coronavirus, poliomyelitis, West Nile virus, COVID-19 associated with SARS-CoV-2, monitoring environmental suitability of Vibrio growth in the Baltic Sea, influenza A(H3N2) variant virus – Hawaii, USA, tick-borne encephalitis in the UK, local transmission of dengue fever in France and babesiosis in the UK.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 June - 4 July 2020 and includes updates on COVID-19, Ebola virus disease, polio, vibrio, West Nile Virus and lyssavirus.
This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and
food are collected annually by the EU Member States (MSs), jointly analysed by EFSA and ECDC and
reported in a yearly EU Summary Report.